289 related articles for article (PubMed ID: 24046283)
1. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.
Bennett PE; Bemis L; Norris DA; Shellman YG
Physiol Genomics; 2013 Nov; 45(22):1049-59. PubMed ID: 24046283
[TBL] [Abstract][Full Text] [Related]
2. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
4. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.
Mo Y; Fang RH; Wu J; Si Y; Jia SQ; Li Q; Bai JZ; She XN; Wang JQ
J Cell Physiol; 2019 Dec; 234(12):23518-23527. PubMed ID: 31219186
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in malignant melanoma.
Völler D; Ott C; Bosserhoff A
Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
8. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
[TBL] [Abstract][Full Text] [Related]
9. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
11. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
12. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling.
Chen XX; Zhang N; Fu XF; Jiang Y; Wang MY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7698-7708. PubMed ID: 32744696
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
Aftab MN; Dinger ME; Perera RJ
Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea regulates the development and survival of B16 Melanoma Cells by upregulating MiR-7013-3p.
Huang YJ; Gao Y; Wang CJ; Han DX; Zheng Y; Wang WH; Jiang H; Yuan B; Zhang JB
Int J Med Sci; 2021; 18(8):1877-1885. PubMed ID: 33746605
[TBL] [Abstract][Full Text] [Related]
19. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.
Zhou WJ; Wang HY; Zhang J; Dai HY; Yao ZX; Zheng Z; Meng-Yan S; Wu K
Aging (Albany NY); 2020 Nov; 12(22):22759-22775. PubMed ID: 33202380
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
